Brief: Peptidream Inc - Agreed Joint Research And Development, Licensing Deal With Merck Unit MSD For New PDPS Drug Discovery
21/12/2022 23:40
Dec 22 (Reuters) - PeptiDream Inc 4587.T :
* AGREED JOINT RESEARCH AND DEVELOPMENT, LICENSING DEAL WITH
MERCK
UNIT MSD FOR NEW PDPS DRUG DISCOVERY
Source text for Eikon: ID:nTSxu8daba
Further company coverage: 4587.T
Recent news on PeptiDream
See all newsTable: Peptidream 6-MTH group results (IFRS)
Brief: Peptidream Inc. - Initiation Of Phase 1 Clinical Trial By Novartis Marks Milestone For Peptidream
Brief: PeptiDream Announces First Dosing Of 64cu-Pd-29,875 In Gastric Cancer Patients
Table: Peptidream -Q1 group results (IFRS)
Brief: Peptidream Announces The Initiation Of Phase 1 Clinical Trial By Its Collaboration Partner